Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Finasteride Treatment Report
What is Finasteride?

Finasteride is used to treat male baldness and for benign prostatic hypertrophy. Off label use after radical prostatectomy in the treatment of prostatic cancer and female hirsutism; may reduce the incidence of prostate cancer.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
Hair loss 4 1
prostate enlargement 2 1
Prostate problems 1 0

See all 5 patients currently taking Finasteride

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 50%
Mild
0 0%
None
1 50%

Most commonly reported side effects

decrease sex drive, sperm production, and pleasure
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  1 mg daily 40 mg monthly 10 mg daily
  3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Finasteride (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
1 100% Doctor's advice: 100%
Side effects too severe
1 100% Side effects too severe: 100%

See all 1 patient who’ve stopped taking Finasteride

Duration See details about how long patients take this treatment ▼

Currently Taking Finasteride

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Finasteride

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 50%
Somewhat
0 0%
A little
1 50%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 50%
$25-49
0 0%
< $25
1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 21, 2010.